<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-CUE5XGT9/ba076831-5d8e-491c-9d4c-e8a49f7f8307/PDF"><dcterms:extent>114 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-CUE5XGT9/7665bb0e-d756-40a2-aceb-91734869cc12/TEXT"><dcterms:extent>29 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="2005-2025"><edm:begin xml:lang="en">2005</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-CUE5XGT9"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-8ER5ZBJN" /><dcterms:issued>2014</dcterms:issued><dc:creator>Anderluh, Marko</dc:creator><dc:creator>Knez, Damijan</dc:creator><dc:format xml:lang="sl">številka:3</dc:format><dc:format xml:lang="sl">letnik:65</dc:format><dc:format xml:lang="sl">str. 227-233</dc:format><dc:identifier>ISSN:0014-8229</dc:identifier><dc:identifier>COBISSID:3692657</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-CUE5XGT9</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko farmacevtsko društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Farmacevtski vestnik</dcterms:isPartOf><dc:subject xml:lang="en">blood-brain barrier</dc:subject><dc:subject xml:lang="sl">farmakološki učinki</dc:subject><dc:subject xml:lang="sl">in silico modeli</dc:subject><dc:subject xml:lang="en">in silico models</dc:subject><dc:subject xml:lang="sl">krvno-možganska pregrada</dc:subject><dc:subject xml:lang="sl">napovedovanje prehajanja</dc:subject><dc:subject xml:lang="en">prediction of permeability</dc:subject><dc:subject xml:lang="sl">prenašalci spojin</dc:subject><dcterms:temporal rdf:resource="2005-2025" /><dc:title xml:lang="sl">Prepustnost krvno-možganske pregrade pri razvoju učinkovin z delovanjem v osrednjem živčevju| Blood-brain barrier permeation in development of central nervous system agents|</dc:title><dc:description xml:lang="sl">Permeability across blood-brain barrier is a necessity for achieving pharmacological effect in the central nervous system. Development of central nervous system agents requires optimization of drug permeability into brain additional to enhancement of other pharmacodynamic and pharmacokinetic parameters. Herein, in silico methods for prediction of blood-brain barrier permeability are reviewed. Futhermore, special attention is paid to the possibilty of active transport as a mechanism of transport as in addition to passive permeability, it can fundamentaly influence the permeability of central nervous system agent</dc:description><dc:description xml:lang="sl">Za dosego farmakološkega učinka v centralnem živčnem sistemu je nujen predpogoj, da učinkovina prehaja preko krvno-možganske pregrade. Pri razvoju učinkovin z delovanjem v centralnem živčevju moramo zato poleg farmakodinamskih in farmakokinetičnih parametrov optimizirati tudi prehajanje spojine v možgane. V preglednem članku so predstavljeni in silico načini napovedovanja prehajanja krvno-možganske pregrade. Poleg pasivnega prehajanja je potrebno upoštevati tudi možnost aktivnega prenosa, ki lahko bistveno vpliva na prehodnost učinkovine</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-CUE5XGT9"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-CUE5XGT9" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-CUE5XGT9/ba076831-5d8e-491c-9d4c-e8a49f7f8307/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko farmacevtsko društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-CUE5XGT9/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-CUE5XGT9" /></ore:Aggregation></rdf:RDF>